Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Opko HealthBELLUS HealthEpizymeAthenexTheravance Biopharma
SymbolNASDAQ:OPKOTCMKTS:BLUSFNASDAQ:EPZMNASDAQ:ATNXNASDAQ:TBPH
Price Information
Current Price$2.17$7.51$11.96$13.78$22.93
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$4.00N/A$18.50$23.8333$49.3333
% Upside from Price Target84.33% upsideN/A54.68% upside72.96% upside115.15% upside
Trade Information
Market Cap$1.34 billion$1.19 billion$1.11 billion$1.08 billion$1.35 billion
Beta2.191.552.46-0.171.72
Average Volume2,749,37261,933538,732381,681197,858
Sales & Book Value
Annual Revenue$990.30 million$30,000.00$21.70 million$89.10 million$60.37 million
Price / Sales1.3539,833.0450.1811.9521.51
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.06 per share$0.25 per share$2.94 per share$1.92 per share($0.93) per share
Price / Book0.7130.044.077.18-24.66
Profitability
Net Income$-153,040,000.00$-7,010,000.00$-123,630,000.00$-117,440,000.00$-215,520,000.00
EPS($0.25)N/A($1.72)($1.44)($3.99)
Trailing P/E Ratio0.000.000.000.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-26.55%-49,910.34%N/A-161.17%-369.67%
Return on Equity (ROE)-12.17%-48.37%-54.00%-85.39%-2,631.15%
Return on Assets (ROA)-8.62%-45.25%-43.79%-45.59%-45.43%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.13%N/A0.03%0.34%N/A
Current Ratio1.21%13.87%10.56%2.62%3.87%
Quick Ratio1.04%13.87%10.56%2.33%3.87%
Ownership Information
Institutional Ownership Percentage24.56%N/A86.32%48.31%84.16%
Insider Ownership Percentage42.25%24.17%16.60%18.80%6.60%
Miscellaneous
Employees5,69010124575363
Shares Outstanding615.60 million159.12 million91.04 million77.28 million56.64 million
Next Earnings Date11/8/2019 (Estimated)11/13/2019 (Estimated)11/1/2019 (Estimated)11/13/2019 (Estimated)11/5/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 Opko HealthBELLUS HealthEpizymeAthenexTheravance Biopharma

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel